Table of Contents

company-logo

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Spyre Therapeutics Dividend Announcement

• Spyre Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Spyre Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Spyre Therapeutics Dividend History

Spyre Therapeutics Dividend Yield

Spyre Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Spyre Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Spyre Therapeutics Financial Ratios

P/E ratio-9.32
PEG ratio-0.09
P/B ratio6.12
ROE-82.81%
Payout ratio0.00%
Current ratio7.32
Quick ratio7.32
Cash Ratio1.24

Spyre Therapeutics Dividend FAQ

Does Spyre Therapeutics stock pay dividends?
Spyre Therapeutics does not currently pay dividends to its shareholders.
Has Spyre Therapeutics ever paid a dividend?
No, Spyre Therapeutics has no a history of paying dividends to its shareholders. Spyre Therapeutics is not known for its dividend payments.
Why doesn't Spyre Therapeutics pay dividends?
There are several potential reasons why Spyre Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Spyre Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Spyre Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Spyre Therapeutics a dividend aristocrat?
Spyre Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Spyre Therapeutics a dividend king?
Spyre Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Spyre Therapeutics a dividend stock?
No, Spyre Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Spyre Therapeutics stocks?
To buy Spyre Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Spyre Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.